A prospective randomized trial of schedules for sclerosing esophageal varices. 1- versus 2-week intervals

H. Higashi, S. Kitano, M. Hashizume, H. Yamaga, K. Sugimachi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A prospective randomized trial was performed to compare the efficacy and complications of 1-week (20 patients) and 2-week (20 patients) interval schedules of endoscopic injection sclerotherapy for patients with esophageal varices; 6 were acute, 3 were elective and 31 were prophylactic cases. There were no significant differences between the 1-week and 2-week interval groups with regard to total number of sclerotherapy sessions, total volume of the sclerosant used (5% ethanolamine oleate) or rate of complications such as pyrexia, stricture and pleural effusion. The incidence of ulcer and/or slough formation after EIS was the same in the two groups. Neither early nor recurrent bleeding occurred in any patient in the two groups. Eradication of varices in the 2-week interval group was achieved significantly earlier (p<0.05) than in the 1-week interval group.

Original languageEnglish
Pages (from-to)337-340
Number of pages4
JournalHepato-Gastroenterology
Volume36
Issue number5
Publication statusPublished - Jan 1 1989

Fingerprint

Esophageal and Gastric Varices
Appointments and Schedules
Sclerotherapy
Sclerosing Solutions
Varicose Veins
Pleural Effusion
Ulcer
Pathologic Constriction
Fever
Hemorrhage
Injections
Incidence

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Higashi, H., Kitano, S., Hashizume, M., Yamaga, H., & Sugimachi, K. (1989). A prospective randomized trial of schedules for sclerosing esophageal varices. 1- versus 2-week intervals. Hepato-Gastroenterology, 36(5), 337-340.

A prospective randomized trial of schedules for sclerosing esophageal varices. 1- versus 2-week intervals. / Higashi, H.; Kitano, S.; Hashizume, M.; Yamaga, H.; Sugimachi, K.

In: Hepato-Gastroenterology, Vol. 36, No. 5, 01.01.1989, p. 337-340.

Research output: Contribution to journalArticle

Higashi, H, Kitano, S, Hashizume, M, Yamaga, H & Sugimachi, K 1989, 'A prospective randomized trial of schedules for sclerosing esophageal varices. 1- versus 2-week intervals', Hepato-Gastroenterology, vol. 36, no. 5, pp. 337-340.
Higashi H, Kitano S, Hashizume M, Yamaga H, Sugimachi K. A prospective randomized trial of schedules for sclerosing esophageal varices. 1- versus 2-week intervals. Hepato-Gastroenterology. 1989 Jan 1;36(5):337-340.
Higashi, H. ; Kitano, S. ; Hashizume, M. ; Yamaga, H. ; Sugimachi, K. / A prospective randomized trial of schedules for sclerosing esophageal varices. 1- versus 2-week intervals. In: Hepato-Gastroenterology. 1989 ; Vol. 36, No. 5. pp. 337-340.
@article{53389a840b294f4dbed67e118cc327e7,
title = "A prospective randomized trial of schedules for sclerosing esophageal varices. 1- versus 2-week intervals",
abstract = "A prospective randomized trial was performed to compare the efficacy and complications of 1-week (20 patients) and 2-week (20 patients) interval schedules of endoscopic injection sclerotherapy for patients with esophageal varices; 6 were acute, 3 were elective and 31 were prophylactic cases. There were no significant differences between the 1-week and 2-week interval groups with regard to total number of sclerotherapy sessions, total volume of the sclerosant used (5{\%} ethanolamine oleate) or rate of complications such as pyrexia, stricture and pleural effusion. The incidence of ulcer and/or slough formation after EIS was the same in the two groups. Neither early nor recurrent bleeding occurred in any patient in the two groups. Eradication of varices in the 2-week interval group was achieved significantly earlier (p<0.05) than in the 1-week interval group.",
author = "H. Higashi and S. Kitano and M. Hashizume and H. Yamaga and K. Sugimachi",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "36",
pages = "337--340",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "5",

}

TY - JOUR

T1 - A prospective randomized trial of schedules for sclerosing esophageal varices. 1- versus 2-week intervals

AU - Higashi, H.

AU - Kitano, S.

AU - Hashizume, M.

AU - Yamaga, H.

AU - Sugimachi, K.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - A prospective randomized trial was performed to compare the efficacy and complications of 1-week (20 patients) and 2-week (20 patients) interval schedules of endoscopic injection sclerotherapy for patients with esophageal varices; 6 were acute, 3 were elective and 31 were prophylactic cases. There were no significant differences between the 1-week and 2-week interval groups with regard to total number of sclerotherapy sessions, total volume of the sclerosant used (5% ethanolamine oleate) or rate of complications such as pyrexia, stricture and pleural effusion. The incidence of ulcer and/or slough formation after EIS was the same in the two groups. Neither early nor recurrent bleeding occurred in any patient in the two groups. Eradication of varices in the 2-week interval group was achieved significantly earlier (p<0.05) than in the 1-week interval group.

AB - A prospective randomized trial was performed to compare the efficacy and complications of 1-week (20 patients) and 2-week (20 patients) interval schedules of endoscopic injection sclerotherapy for patients with esophageal varices; 6 were acute, 3 were elective and 31 were prophylactic cases. There were no significant differences between the 1-week and 2-week interval groups with regard to total number of sclerotherapy sessions, total volume of the sclerosant used (5% ethanolamine oleate) or rate of complications such as pyrexia, stricture and pleural effusion. The incidence of ulcer and/or slough formation after EIS was the same in the two groups. Neither early nor recurrent bleeding occurred in any patient in the two groups. Eradication of varices in the 2-week interval group was achieved significantly earlier (p<0.05) than in the 1-week interval group.

UR - http://www.scopus.com/inward/record.url?scp=0024385972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024385972&partnerID=8YFLogxK

M3 - Article

C2 - 2695448

AN - SCOPUS:0024385972

VL - 36

SP - 337

EP - 340

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 5

ER -